The Food and Drug Administration (FDA) has given its approval for the updated Covid-19 vaccines developed by Pfizer and Moderna. This development paves ...

UBS analyst Eliana Merle has upgraded shares of biotech company Moderna to Buy from Neutral, attributing the move to investors’ lack of appreciation ...